↧
Atomwise Appoints Gavin Hirst, Ph.D., as Chief Scientific Officer
Veteran drug hunter adds discovery expertise to technology-enabled biopharma company SAN FRANCISCO, Calif. — September 14, 2022 — Atomwise, a leader in using artificial intelligence (AI) for small...
View ArticleAtomwise Announces Nomination of its First AI-Driven Development Candidate...
SAN FRANCISCO–(BUSINESS WIRE)– Atomwise, a leader in using AI for small molecule drug discovery, today announced the nomination of its first AI-driven development candidate focused on TYK2 inhibition...
View ArticleAtomwise Publishes Results from 318-Target Study Showcasing AtomNet AI...
San Francisco, CA – April 2, 2024 – Atomwise announced today results from the AIMS (Artificial Intelligence Molecular Screen) initiative that establish the AtomNet AI Platform as a viable alternative...
View Article
More Pages to Explore .....